about
MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastomaNeuroblastoma tumorigenesis is regulated through the Nm23-H1/h-Prune C-terminal interaction.Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid TumorsH-Prune through GSK-3β interaction sustains canonical WNT/β-catenin signaling enhancing cancer progression in NSCLCThe micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma.Cytogenetic prognostication within medulloblastoma subgroups.In vivo bioluminescence imaging using orthotopic xenografts towards patient's derived-xenograft Medulloblastoma models.MiR-34a deficiency accelerates medulloblastoma formation in vivo.A therapeutic approach to treat prostate cancer by targeting Nm23-H1/h-Prune interaction.Early targets of miR-34a in neuroblastoma.Novel pyrimidopyrimidine derivatives for inhibition of cellular proliferation and motility induced by h-prune in breast cancer.The metallophosphodiesterase Mpped2 impairs tumorigenesis in neuroblastoma.The miR-17-92 microRNA cluster regulates multiple components of the TGF-β pathway in neuroblastoma.Mapping functional interaction sites of human prune C-terminal domain by NMR spectroscopy in human cell lysates.A Hematogenous Route for Medulloblastoma Leptomeningeal Metastases.RIP1-HAT1-SirT complex identification and targeting in treatment and prevention of cancer.Metastatic group 3 medulloblastoma is driven by PRUNE1 targeting NME1-TGF-β-OTX2-SNAIL via PTEN inhibition.Gene methylation in liquid biopsy and risk of recurrence in lung cancer.A Hematogenous Route for Medulloblastoma Leptomeningeal MetastasesHepatocellular carcinoma: H-Prune gene regulatory networksAfatinib, a lung cancer inhibitor of ErbB familyLocoregional delivery of CAR T cells to the cerebrospinal fluid for treatment of metastatic medulloblastoma and ependymomaRecurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma
P50
Q27320938-51C5D348-AC9E-4557-8413-D67CAB52E0B1Q30536922-58CE48B3-CF29-47CE-80A6-BCC75C8A5FD5Q33882326-8FB9A3A5-6662-4B96-9BB0-6820A37DF9E6Q34221808-29F3E519-BFCC-477D-A18B-A0DD857A0EEBQ35914487-C1FFDF37-6033-4BBA-BCBE-28BBFF4D09EAQ37627692-4CC127D8-AA24-4780-BB36-23B0F0701B54Q38725939-9469F229-C1C0-46BE-A21F-16013F0545C4Q38944728-BAC2C237-51EA-4BA9-AE58-C7A18E8BBEDFQ38964540-8675F84C-6366-440B-A096-062D941D9433Q38986499-A32638B4-B648-4F02-9C1F-ACED3741E11AQ39261060-CF47E53C-442C-4665-9623-778818C8F1DCQ39409377-2B623BE0-81AF-4073-B3B7-E500914CAD55Q39621978-90F6D4D3-39F0-4793-97E1-EA4992D824BEQ47793033-4A880E5A-9526-490D-9827-162E5854148DQ50422142-917F937E-7A6E-4A4B-933D-2035D67313A9Q52357060-84DA675A-BD0B-4F1F-B028-19B16640E626Q52371562-198642CC-A1D5-4693-B30D-F439F8D5959BQ55172381-5FDBC74B-9E24-464E-BE85-C0663C57492CQ57261173-70894288-4A8E-43AC-9A52-2CC4300DECE3Q64286947-7DC57F6A-62E8-41BE-A368-4036CA99703EQ87673888-2CE73AB7-D9D1-4938-9C26-54B376A7F348Q93271206-AC70A3DD-D225-4123-904E-62630E944AB7Q95807738-9D2B6E00-C8B3-450D-B85C-2866B9E2BABF
P50
description
researcher ORCID ID = 0000-0001-8551-9431
@en
wetenschapper
@nl
name
Pasqualino de Antonellis
@ast
Pasqualino de Antonellis
@en
Pasqualino de Antonellis
@es
Pasqualino de Antonellis
@nl
type
label
Pasqualino de Antonellis
@ast
Pasqualino de Antonellis
@en
Pasqualino de Antonellis
@es
Pasqualino de Antonellis
@nl
prefLabel
Pasqualino de Antonellis
@ast
Pasqualino de Antonellis
@en
Pasqualino de Antonellis
@es
Pasqualino de Antonellis
@nl
P106
P1153
36665974800
P31
P496
0000-0001-8551-9431